AU2260588A - Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine - Google Patents
Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccineInfo
- Publication number
- AU2260588A AU2260588A AU22605/88A AU2260588A AU2260588A AU 2260588 A AU2260588 A AU 2260588A AU 22605/88 A AU22605/88 A AU 22605/88A AU 2260588 A AU2260588 A AU 2260588A AU 2260588 A AU2260588 A AU 2260588A
- Authority
- AU
- Australia
- Prior art keywords
- neutralisation
- vaccine
- fragments
- gene
- encoding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU22605/88A AU621065B2 (en) | 1987-08-10 | 1988-08-10 | Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPI364387 | 1987-08-10 | ||
AUPI3643 | 1987-08-10 | ||
AU22605/88A AU621065B2 (en) | 1987-08-10 | 1988-08-10 | Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine |
PCT/AU1988/000298 WO1989001514A1 (en) | 1987-08-10 | 1988-08-10 | Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2260588A true AU2260588A (en) | 1989-03-09 |
AU621065B2 AU621065B2 (en) | 1992-03-05 |
Family
ID=31891613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU22605/88A Expired AU621065B2 (en) | 1987-08-10 | 1988-08-10 | Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU621065B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114478714A (en) * | 2022-02-04 | 2022-05-13 | 通化师范学院 | Method for analyzing expression and immunogenicity of recombinant human rotavirus VP7 protein |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5736286A (en) * | 1985-05-14 | 1986-11-20 | Commonwealth Scientific And Industrial Research Organisation | Rotavirus antigens |
EP0251467A3 (en) * | 1986-06-20 | 1988-07-20 | Abbott Laboratories | Compositions and methods of use for a major outer capsid protein (vp7) of rotavirus sa-11 |
US5186933A (en) * | 1986-12-30 | 1993-02-16 | Baylor College Of Medicine | Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system |
-
1988
- 1988-08-10 AU AU22605/88A patent/AU621065B2/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114478714A (en) * | 2022-02-04 | 2022-05-13 | 通化师范学院 | Method for analyzing expression and immunogenicity of recombinant human rotavirus VP7 protein |
Also Published As
Publication number | Publication date |
---|---|
AU621065B2 (en) | 1992-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL339735A1 (en) | Pappiloma virus capsomer vaccine compositions and methods of applying them | |
EP0402354A4 (en) | Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine | |
EP0757717A4 (en) | Papillomavirus vaccines | |
AU7966987A (en) | Empty viral capsid vaccines | |
AU5166693A (en) | Endotracheal tube for face, chin and neck surgery | |
EP0467700A3 (en) | Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties | |
EP0681585A4 (en) | Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use. | |
AU1255383A (en) | Foot and mouth disease viral antigenic peptides | |
IL117115A (en) | Process for preparing recombinant adenovirus genomes | |
IL93957A0 (en) | Bordetella outer membrane proteins,their use in vaccines and their expression | |
AU1927797A (en) | Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines | |
EP0888777A3 (en) | Recombinant bovine herpesvirus type 1 polyptpetides and vaccines | |
HUP9901035A3 (en) | Parapoxviruses containing foreign dna, their production and their use in vaccines | |
EP0265457A4 (en) | Vaccine and implant. | |
EP0187722A3 (en) | Antibiotics called "chloropolysporins b and c", a process for their preparation, and their therapeutic and veterinary use | |
AU2260588A (en) | Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine | |
NZ239948A (en) | Hiv gp160 modified at positions 502 and 510, vaccines and recombinant methods for producing modified gp160 | |
EP0110791A3 (en) | Peptides containing an immunogenic site of the poliovirus, and dna's containing nucleotide fragments encoding for these peptides | |
AU3065892A (en) | Pneumococcal fimbrial protein a vaccines | |
AR243237A1 (en) | Human ciliary neuronotrophic factor, dna sequence encoding the factor, and production of the factor by recombinant technology | |
EP0474676A4 (en) | Production of ibdv vp2 in highly immunogenic form | |
DK575787A (en) | Recombinant HCMV-derived plasmid, its preparation and use | |
IL112993A0 (en) | Recombinant niruses, their preparation and their use in gene therapy | |
AU1825895A (en) | Retroviral vaccines, vaccination and immune-therapy for retroviral infections | |
AU697814B2 (en) | Improvements in sustainable cell line for the production of Marek's disease vaccines |